Navigation Links
JPIDS: Releases consensus statement on research definitions for drug-resistant TB in children
Date:5/21/2013

ARLINGTON, VA, May 21, 2013The Journal of the Pediatric Infectious Diseases Society (JPIDS) today released its June issue, which includes a consensus statement of the global Sentinel Project on Pediatric Drug-Resistant Tuberculosis. It establishes standardized definitions, measurements, and other key attributes that will effect research. This is the first step as the group of international stakeholders collaborate to raise visibility and share evidence and resources that can improve children's access to prompt and effective treatment.

Consensus Statement on Research Definitions for Drug-Resistant Tuberculosis in Children

"Colonization Pressure"(CP) is one predictor of healthcare associated Methicillin-resistant Staphylococcus aureus (MRSA) infections. It is a gauge of the proportion of patients on a given unit colonized during a defined period. As new strains of MRSA emerge outside the healthcare environment, Rodriguez, et al, hypothesized that CP would also be a good measurement tool for households, where S aureus infections cluster, and that cases with a higher baseline household colonization pressure (HHCP) would be at greater risk for persistent S aureus colonization and recurrent S aureus skin and soft tissue infection (SSTI). They conducted an individual vs. household decolonization intervention study for pediatric patients with community-onset SSTI and colonization. Patients colonized or infected with either MRSA or Methicillin-susceptible Staphylococcus aureus (MSSA) were eligible, and the team shared decolonization strategies with the households.

The team evaluated 92 cases and 296 of their household contacts quarterly for a year. They found that high MRSA HHCP is associated with persistent MRSA colonization in children. Surprisingly, although cases with household contacts that experienced an SSTI in the past year had a higher baseline S aureus HHCP than those w
'/>"/>

Contact: Jodie Klein
jodieklein@kleinonpoint.com
703-528-3333
Pediatric Infectious Diseases Society
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Narconon Releases Report on its Very First Narconon Program, the First of 23 Reviews or Evaluations of Results up to 2009
2. Law Firm Releases New Informational Graphic on the Basics of Understanding Medical Malpractice Cases
3. MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo
4. Ohio Wrongful Death Lawyer Releases A New Video Entitled “What Is A Wrongful Death Claim In Ohio?”
5. hCG Lifestyle Releases List of the Top Editor's Choice for HCG Drops
6. Palomar Modular Buildings Releases Innovative Commercial Building Floor Plans
7. BroadConnect Releases a Beta Portal Tool to Aid in Partner Success
8. SF Cable Releases Amplified HD Digital Outdoor Antenna with Motorized 360 Degree Rotation, UHF/VHF/FM Radio
9. TransactRx Releases Part 1 of Series – Buying Vaccines from Group Purchasing Organizations
10. Glow Bug Cloth Diapers Releases the Revolutionary 360° Gusset
11. Health Care Without Harm Releases Report on Healthy Food in Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... no secret that millions of Americans are struggling with ... Abuse, nearly 24 million Americans are using some form ... fact that the total number of users has increased ... struggle with substance abuse often feel there may never ... has released updated lists of substance abuse resources ...
(Date:8/20/2014)... 2014 A Missouri federal judge has remanded ... were treated with GranuFlo and NaturaLyte to the City of ... Baron and Budd. The judge rejected an assertion by the ... were invalid. (McGee, et al. v. Fresenius Medical Care North ... Medical Care, is the manufacturer of the dialysis products GranuFlo ...
(Date:8/20/2014)... -- Taking the widely used antibiotic clarithromycin ... causes, a new study suggests. Because millions of ... urgent confirmation, said the Danish researchers behind the study. ... and that guidelines for the use of the drug ... One heart expert wasn,t surprised by the finding, ...
(Date:8/20/2014)... Chemically extracted acellular allogeneic nerve, from which ... have been removed, reduced postoperative immune rejection. ... neural substrates and base materials, such as ... can provide a good scaffold in the ... allogeneic nerve, similar to autologous nerve transplantation, ...
(Date:8/20/2014)... Angeles, CA (PRWEB) August 20, 2014 If ... has found a cure for it. With extensive research on ... provider named ‘MetroMD’ claims to have perfected the art of ... you a brand new younger look with their revolutionary anti-aging ... secrets of the 21st century fountain of youth, the MD ...
Breaking Medicine News(10 mins):Health News:Re-Launched AbuseTreatmentCenters.net Offering New List of Substance Abuse Resources 2Health News:GranuFlo/NaturaLyte Case Remanded to State Court By Missouri Federal Judge, Baron and Budd Reports 2Health News:Antibiotic Might Raise Heart Risks for Some 2Health News:MetroMD Offers Revolutionary Anti-aging Hormone Therapy in Hollywood Area 2
... may indicate underlying disease, study finds , , FRIDAY, Aug. 8 ... play a pivotal role in increasing an older American,s risk ... a new report says. , Levels of adiponectin increase in ... the cardiovascular health of older people, according to the new ...
... Alaska The University of Alaska Fairbanks campus will be ... 12-14, 2008. , The biennial conference is organized in ... Arctic Region and brings together international participants to address ... host to the 2008 conference. , More than150 guests ...
... Delivers Cheer, Medication and Equipment to Young Patients and Helps ... Raise Money for Make-A-Wish ... general,availability of its train-themed "JR" autonomous mobile robot to children,s,hospitals ... the,national Make-A-Wish Foundation for each JR TUG that is deployed. ...
... 1-inch cut behind uterus and into woman,s body cavity ... they say may be the first operation of its ... Hospital/Columbia University Medical Center removed a woman,s gallbladder without ... as part of an ongoing clinical research trial, involved ...
... EDT, Thursday, ... August 14, PRINCETON, ... advanced wound care products,announced plans to release its second quarter 2008 results ... the Company will,hold a conference call that same day to discuss the ...
... Inc. (NYSE: HGR ) is pleased to ... Hanger Orthopedic Group, Inc. to "positive",from "stable." Moody,s ... "We are pleased with the outlook change ... the last ten quarters," remarked George McHenry,Hanger,s Chief ...
Cached Medicine News:Health News:Fat Cell Protein Boosts Heart Attack Risk in Elderly 2Health News:UAF to host Eighth Conference of Arctic Parliamentarians 2Health News:Charlotte Children's Hospital Gets a Delivery from Aethon's Train-Themed Robot This Fall 2Health News:Charlotte Children's Hospital Gets a Delivery from Aethon's Train-Themed Robot This Fall 3Health News:New Technique Removes Gallbladder Without External Incisions 2Health News:Derma Sciences Conference Call Advisory 2
(Date:8/20/2014)... , Aug. 20, 2014  Glades Drugs, an independent ... is proud to announce its expansion into a new corporate ... will feature an 8,000-square-foot office space and state of the ... applications for 100 open positions for the new facility. ... Lantana Road will serve as the chain,s corporate headquarters and ...
(Date:8/20/2014)... Reportlinker.com announces that a new market research report ... Patient Scales Industry http://www.reportlinker.com/p01374301/Global-Patient-Scales-Industry.html ... markets for Patient Scales in US$ Thousand by ... Baby Scales, Chair Scales, and Under Bed Scales. ... US, Canada, Japan, Europe, Asia-Pacific, Latin America, and ...
(Date:8/20/2014)... 2014 Phase I Trial of ... KalVista Pharmaceuticals ("KalVista"), an ophthalmology company with ... that it has begun a Phase I, First in ... for the treatment of DME. The study,s Principal Investigator ... Institute, Joslin Diabetes Center; Harvard Medical School Department of ...
Breaking Medicine Technology:Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4
... Medical ® today announced that it has closed on ... by Singapore-based Crescent Point Group, with existing investors, Maverick ... Ventures and Affinity Capital, making additional investments. Sami Sindi, ... board of directors. Moelis & Company acted as financial ...
... Jan. 9, 2012  MolecularHealth, a clinico-molecular informatics company, ... two next generation product lines that translate patient-specific ... scientific evidence into safer, more effective drug choices ... producing genomic information falling drastically and clinical data ...
Cached Medicine Technology:Uptake Medical Announces Successful Completion of Series C Financing 2MolecularHealth to Introduce Knowledge-Driven Solutions that Enhance Drug Safety and Enable Molecularly-Guided Treatment Decision Support 2MolecularHealth to Introduce Knowledge-Driven Solutions that Enhance Drug Safety and Enable Molecularly-Guided Treatment Decision Support 3
The Calcitonin ELISA is intended for the quantitative determination of Calcitonin in human serum....
... wavelength (532 nm and 940 nm) laser ... solution. This solid-state laser quickly and effectively ... vulgaris. VariLite offers the clinical versatility to ... deeper, larger vessels in a convenient, affordable ...
... PREMIUM SURGICLIP™ clip applier consists of an applier ... 15 or 20 titanium clips. , ,The ... or other tubular structure. As the handles of ... closed around the vessel or structure. As the ...
The LIGACLIP ERCA Endoscopic Rotating Multiple Clip Applier is intended for use on tubular structures or vessels wherever a metal ligating clip is indicated. The tissue being ligated should be consis...
Medicine Products: